Improving diagnostic accuracy for probable and definite Ménière's disease using magnetic resonance imaging

Jinye Li1, Linsheng Wang1, Na Hu1

  • 1Department of Radiology, Shandong Provincial ENT Hospital, Shandong University, 4 Duan Xing-Xi Road, Jinan, China.

Neuroradiology
|June 16, 2023
PubMed
Abstract

Insights

Magnetic resonance imaging (MRI) using perilymphatic enhancement (PE) and endolymphatic hydrops (EH) shows improved diagnostic accuracy for Ménière

Area of Science:

  • Otolaryngology
  • Radiology
  • Neuroscience

Background:

  • Ménière's disease (MD) diagnosis relies on clinical symptoms, with imaging playing a supportive role.
  • Perilymphatic enhancement (PE) and endolymphatic hydrops (EH) are key imaging biomarkers in MD.
  • Accurate differentiation between probable and definite MD is crucial for patient management.

Purpose of the Study:

  • To evaluate the efficacy of MRI in enhancing diagnostic accuracy for definite and probable Ménière's disease.
  • To assess the utility of perilymphatic enhancement (PE) and endolymphatic hydrops (EH) in MRI-based MD diagnosis.

Main Methods:

  • 363 patients with unilateral MD (75 probable, 288 definite) underwent MRI.
  • A 3D zoomed imaging technique was used 6 hours post-gadolinium injection.
  • PE presence, EH grading, and location were analyzed and compared between MD groups.

Main Results:

  • Definite MD showed more severe cochlear and vestibular EH grading compared to probable MD.
  • Distinct EH locations were observed between definite and probable MD groups.
  • The combination of PE and EH parameters yielded a higher area under the curve (AUC) for definite MD diagnosis (0.82) than individual parameters.

Conclusions:

  • Combining PE and EH parameters in MRI significantly improves diagnostic accuracy for probable and definite MD.
  • MRI findings, particularly the combined assessment of PE and EH, are clinically valuable for MD diagnosis.
  • This approach aids in differentiating between stages of Ménière's disease.